BCL2 and cancer: SAL also inhibits K-ras [169], Notch [82] and Hedgehog signaling [170], (ii) NIG is also a potent modulator of the Wnt signaling pathway [6] and (iii) OBT targets cancer stem cells via disruption of BCL-2-dependent oxidative phosphorylation [14].